secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2025-06-03T23:59:59+00:00
Accession:  0001641172-25-013396
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio doubles HQ leased space to 13,242 RSF; lease extended to Feb 2033
-----------------------------------------------------------------------------

- Lease amendment doubles space from 6,708 to 13,242 rentable square feet on Building's 2nd floor.
- Term extended seven years to February 28, 2033; annual base rent approx. $330,000 ($24.75/RSF).
- Relocation from 4th floor to 2nd floor effective June 1, 2025; prior lease terminated.
- Employees from Philadelphia R&D center to be relocated after its lease expires June 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000164117225013396/0001641172-25-013396-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000164117225013396/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-013396

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer